VA Now Covers Cost of the Levo System for Tinnitus Treatment

PORTLAND, Ore., Feb. 26, 2019 /PRNewswire/ -- Otoharmonics Corporation, a U.S. veteran-owned company offering sound therapy for tinnitus management, has been awarded a five-year Federal Supply Schedule Medical Equipment and Supply contract, making Levo available immediately to patients receiving care within the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Heads Services, and Public Health Services.

Compatible with the Clinical Practice Guidelines for Tinnitus published by the American Academy of

Otolaryngologists and the VA's Progressive Tinnitus Management Program, the Levo System's sleep therapy has been shown to reduce the level of tinnitus intensity and improve the quality of life in several published peer-reviewed studies, including a randomized controlled study by the National Center for Rehabilitative Auditory Research at the VA Portland Health Care System.   

"Increasing access to affordable, evidence-based tinnitus care for U.S. service men and women has been an ongoing focus for Otoharmonics," said Michael Baker, CEO. "The FSS award is a significant step towards expanding care within this underserved patient population."

Tinnitus is the number one service-related disability among U.S. veterans, according to the American Tinnitus Association. An often-overlooked outcome of active duty, tinnitus is typically a result of exposure to loud noise. Whether it's from a high noise environment such as flight, use of heavy machinery, or being near severe and sudden explosives, the effects of tinnitus can be long-lasting. Left untreated, symptoms may increase over time and significantly impact the quality of life.

The Levo System is an FDA-cleared medical device that works in concert with the brain's natural restorative and learning processes. Designed for home use, those suffering from buzzing or ringing in the ears listen to personalized sound therapy while sleeping to gain relief. Over time, the brain learns to ignore the tinnitus perception, resulting in a reduction of tinnitus intensity and negative impact.

About Otoharmonics Corporation
Otoharmonics Corporation is a privately held company with headquarters in Portland, Oregon USA. As an international team of world?class neuroscientists, clinicians, business professionals, and patients, Otoharmonics has developed the Levo System for tinnitus management, which is specifically designed for use during sleep. The FDA-cleared system utilizes Apple mobile digital devices to offer user-friendly custom sound therapy based on the specific needs of the individual. To learn more visit http://otoharmonics.com or call 503.336.9906.

Otoharmonics and Levo are registered trademarks of Otoharmonics Corporation.

Media contact:
Brenda Edin
[email protected]
503-336-9906

SOURCE Otoharmonics Corporation